Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K113823
    Date Cleared
    2013-03-27

    (456 days)

    Product Code
    Regulation Number
    866.5510
    Reference & Predicate Devices
    N/A
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Hevylite™ Human IgM Kappa Kit for use on Siemens BN™II is intended for the in vitro quantification of IgM Kappa (combined u heavy and K light chain) concentration in human serum on the Siemens Behring Nephelometer™ II (BN™ II). The test result is to be used with previously diagnosed Waldenstoms Macrolobulinaemiain conjunction with other clinical and laboratory findings. This assay has not been established for the diagnosis, monitoring and prognosis of Waldenstroms macroglbulinaemia.

    Hevylite™ Human IgM Lambda Kit for use on Siemens BN™II is intended for the in vitro quantification of IgM Lambda (combined u heavy and À light chain) concentration in human serum on the Siemens Behring Nephelometer™ II (BN™ II). The test result is to be used with previously diagnosed Waldenstoms Macrolobulinaemia in conjunction with other clinical and laboratory findings. This assay has not been established for the diagnosis, monitoring and prognosis of Waldenstroms macrogibulinaemia.

    Device Description

    Not Found

    AI/ML Overview

    The provided document is a 510(k) premarket notification letter from the FDA for an IVD (In Vitro Diagnostic) device. It does not describe a study that uses AI or involves human readers, nor does it provide acceptance criteria and performance data in the structured format requested. Instead, it confirms the substantial equivalence of the "Hevylite™ Human IgM Kappa Kit" and "Hevylite™ Human IgM Lambda Kit" to legally marketed predicate devices.

    The document focuses on:

    • Device Name: Hevylite™ Human IgM Kappa Kit and Hevylite™ Human IgM Lambda Kit for use on Siemens BN™ II Systems.
    • Intended Use: In vitro quantification of IgM Kappa and IgM Lambda concentrations in human serum using the Siemens Behring Nephelometer™ II (BN™ II). These results are to be used with previously diagnosed Waldenstroms Macroglobulinemia, in conjunction with other clinical and laboratory findings.
    • Limitation: The assay has not been established for the diagnosis, monitoring, and prognosis of Waldenstroms Macroglobulinemia.
    • Regulatory Information: Regulation number, name, class, product code, and a statement of substantial equivalence to predicate devices.

    Therefore, it is not possible to extract the requested information (acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth types, or training set details) from this document, as it pertains to an IVD device approval and not an AI/ML-based diagnostic study.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1